Smartleaf Asset Management LLC Krystal Biotech, Inc. Transaction History
Smartleaf Asset Management LLC
- $1.13 Trillion
- Q2 2025
A detailed history of Smartleaf Asset Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 210 shares of KRYS stock, worth $39,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210
Previous 315
33.33%
Holding current value
$39,307
Previous $57.9 Million
49.66%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding KRYS
# of Institutions
315Shares Held
24.7MCall Options Held
417KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$528 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$498 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$254 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$176 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.8B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...